Now showing items 1-2 of 2

  • International consensus on quality standards for brain health-focused care in multiple sclerosis. 

    Hobart, J; Bowen, A; Pepper, G; Crofts, H; Eberhard, L; Berger, T; Boyko, A; Boz, C; Butzkueven, H; Celius, EG; Drulovic, J; Flores, J; Horáková, D; Lebrun-Frénay, C; Marrie, RA; Overell, J; Piehl, F; Rasmussen, PV; Sá, MJ; Sîrbu, C-A; Skromne, E; Torkildsen, Ø; van Pesch, V; Vollmer, T; Zakaria, M; Ziemssen, T; Giovannoni, G
    BACKGROUND:: Time matters in multiple sclerosis (MS). Irreversible neural damage and cell loss occur from disease onset. The MS community has endorsed a management strategy of prompt diagnosis, timely intervention and ...
  • Measuring treatment satisfaction in MS: Is the Treatment Satisfaction Questionnaire for Medication fit for purpose? 

    Vermersch, P; Hobart, J; Dive-Pouletty, C; Bozzi, S; Hass, S; Coyle, PK (England, 2017-04)
    BACKGROUND: The Treatment Satisfaction Questionnaire for Medication (TSQM) was designed to assess patient treatment satisfaction in chronic diseases. Its performance has not been examined in multiple sclerosis (MS). The ...

All items in PEARL are protected by copyright law.
Author manuscripts deposited to comply with open access mandates are made available in accordance with publisher policies. Please cite only the published version using the details provided on the item record or document. In the absence of an open licence (e.g. Creative Commons), permissions for further reuse of content should be sought from the publisher or author.
Theme by 
@mire NV